Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors

SIMPLE SUMMARY: Ovarian cancer treatment is the deadliest of gynecological cancers but the introduction of target therapies in its therapeutic algorithm has significantly improved outcomes. The aim of this article was to provide a review of completed and ongoing clinical trials involving the use of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancers (Basel)
Hoofdauteurs: Nero, Camilla, Ciccarone, Francesca, Pietragalla, Antonella, Duranti, Simona, Daniele, Gennaro, Salutari, Vanda, Carbone, Maria Vittoria, Scambia, Giovanni, Lorusso, Domenica
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2021
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7999042/
https://ncbi.nlm.nih.gov/pubmed/33803954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061298
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items